{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:44:52Z","timestamp":1774359892838,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T00:00:00Z","timestamp":1411603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12011-014-0133-2","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T15:21:24Z","timestamp":1411572084000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["MDR1 and Cytochrome P450 Gene-Expression Profiles as Markers of Chemosensitivity in Human Chronic Myelogenous Leukemia Cells Treated with Cisplatin and Ru(III) Metallocomplexes"],"prefix":"10.1007","volume":"163","author":[{"given":"Cesar Augusto Sam Tiago","family":"Vilanova-Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hellen Karine Paes","family":"Porto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Carlos Gomes","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Pereira","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner Batista","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elis\u00e2ngela de Paula","family":"Silveira-Lacerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"key":"133_CR1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/2193-1801-3-301","volume":"3","author":"FC Pereira","year":"2014","unstructured":"Pereira FC, Lima AP, Vilanova-Costa CAST, Pires WCP, Ribeiro ASBB, Pereira LCG, Pavanin LA, dos Santos WB, Silveira-Lacerda EP (2014) Cytotoxic effects of the compound cis-tetraammine(oxalato)ruthenium(III) dithionate on K-562 human chronic myelogenous leukemia cells. Springer Plus 3:301","journal-title":"Springer Plus"},{"key":"133_CR2","doi-asserted-by":"crossref","unstructured":"Deininger MW (2008) Chronic myeloid leukemia: a historical perspective. American Society of Hematology Education Program Book, 50th Anniversary Review 418","DOI":"10.1182\/asheducation-2008.1.418"},{"key":"133_CR3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s10495-008-0305-7","volume":"14","author":"R Srabanti","year":"2009","unstructured":"Srabanti R, Jayashree B, Labanya M, Kausik P, Dipyaman G, Sandip B, Monidipa G, Nabendu B, Utpal C, Santu B (2009) N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide. Apoptosis 14:298\u2013308","journal-title":"Apoptosis"},{"key":"133_CR4","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MWN Deininger","year":"2000","unstructured":"Deininger MWN, Goldman JM, Melo JV (2000) The molecular biology of chronic myeloid leukemia. Blood 96:3343\u20133356","journal-title":"Blood"},{"issue":"6","key":"133_CR5","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1182\/blood.V101.6.2368","volume":"101","author":"FX Mahon","year":"2003","unstructured":"Mahon FX, Belloc F, Lagarde V, Chollet C, Moreau-Gaudry F, Reiffers J, Goldman JM, Melo JV (2003) MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models. Blood 101(6):2368\u20132373","journal-title":"Blood"},{"key":"133_CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/bbrc.2000.2902","volume":"273","author":"D Runge","year":"2000","unstructured":"Runge D, Kohler C, Kostrubsky VE, Jager D, Lehmann T, Runge DM, May U, Stolz DB, Strom SC, Fleig WE, Michalopoulos GK (2000) Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes. Biochem Biophys Res Commun 273:333\u2013341","journal-title":"Biochem Biophys Res Commun"},{"key":"133_CR7","doi-asserted-by":"crossref","unstructured":"Coburger C, Lage H, Moln\u00e1r J, Hilgeroth A (2009) Impact of novel MDR modulators on human cancer cells: reversal activities and induction studies. Pharm Res 26(1)","DOI":"10.1007\/s11095-008-9736-7"},{"issue":"5","key":"133_CR8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.leukres.2008.09.024","volume":"33","author":"Y Assef","year":"2009","unstructured":"Assef Y, Rubio F, Col\u00f3 G, del M\u00f3naco S, Costas MA, Kotsias BA (2009) Imatinib resistance in multidrug-resistant K562 human leukemic cells. Leuk Res 33(5):710\u2013716","journal-title":"Leuk Res"},{"key":"133_CR9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.drudis.2009.02.002","volume":"14","author":"A Alama","year":"2009","unstructured":"Alama A, Tasso B, Novelli F, Sparatore F (2009) Organometallic compound in oncology: implications of novel organotins as antitumor agents. Drug Discov Today 14:500\u2013508","journal-title":"Drug Discov Today"},{"key":"133_CR10","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1021\/om060394o","volume":"25","author":"A Dorcier","year":"2006","unstructured":"Dorcier A, Ang WH, Bola\u00f1o S, Gonsalvi L, Juillerat-Jeannerat L, Laurenczy G, Peruzzini M, Phillips AD, Zanobini F, Dyson PJ (2006) In vitro evaluation of rhodium and osmium RAPTA analogues: the case for organometallic anticancer drugs not based on ruthenium. Organometallics 25:4090\u20134096","journal-title":"Organometallics"},{"issue":"8","key":"133_CR11","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ctrv.2007.07.013","volume":"33","author":"B Stordal","year":"2007","unstructured":"Stordal B, Pavlakis N, Davey R (2007) A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship. Cancer Treat Rev 33(8):688\u2013703","journal-title":"Cancer Treat Rev"},{"key":"133_CR12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neulet.2005.08.068","volume":"392","author":"K Jirsova","year":"2006","unstructured":"Jirsova K, Mandys V, Gispen WH, Bar PR (2006) Cisplatin-induced apoptosis in cultures of human Schwann cell. Neurosci Lett 392:22\u201326","journal-title":"Neurosci Lett"},{"key":"133_CR13","first-page":"353","volume":"17","author":"G Sava","year":"2000","unstructured":"Sava G, Bergamo A (2000) Ruthenium-based compounds and tumour growth control (review). Int J Oncol 17:353\u2013365","journal-title":"Int J Oncol"},{"issue":"9","key":"133_CR14","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1021\/jm070039f","volume":"50","author":"CA Vock","year":"2007","unstructured":"Vock CA, Ang WH, Scolaro C, Phillips AD, Lagopoulos L, Juillerat-Jeanneret L, Sava G, Scopelliti R, Dyson PJ (2007) Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms. J Med Chem 50(9):2166\u20132175","journal-title":"J Med Chem"},{"key":"133_CR15","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1021\/ic00219a055","volume":"24","author":"LA Pavanin","year":"1985","unstructured":"Pavanin LA, Giesbrecht E, Tfouni E (1985) Synthesis and properties of the ruthenium(II) complexes cis-Ru(NH3)4(isn)L2+ spectra and reduction potentials. Inorg Chem 24:4444\u20134446","journal-title":"Inorg Chem"},{"issue":"3","key":"133_CR16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12011-008-8272-y","volume":"128","author":"FC Pereira","year":"2009","unstructured":"Pereira FC, Vilanova-Costa CAST, Lima AP, Ribeiro ASBB, da Silva HD, Pavanin LA, Silveira-Lacerda EP (2009) Cytotoxic and genotoxic effects of cis-tetraammine(oxalato)ruthenium(III) dithionate on the root meristem cells of Allium cepa. Biol Trace Elem Res 128(3):258\u2013268","journal-title":"Biol Trace Elem Res"},{"key":"133_CR17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12011-009-8440-8","volume":"133","author":"EP Silveira-Lacerda","year":"2010","unstructured":"Silveira-Lacerda EP, Vilanova-Costa CAST, Pereira FC, Hamaguchi A, Pavanin LA, Goulart LR, Homsi-Brandenburgo MI, Santos WB, Soares AM, Nomizo A (2010) The ruthenium complex cis-(dichloro)tetraammineruthenium(III) chloride presents immune stimulatory activity on human peripheral blood mononuclear cells. Biol Trace Elem Res 133:270\u2013283","journal-title":"Biol Trace Elem Res"},{"key":"133_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"16","author":"T Mosman","year":"1983","unstructured":"Mosman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 16:55\u201363","journal-title":"J Immunol Methods"},{"key":"133_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-0270(99)00193-4","volume":"96","author":"D Lobner","year":"2000","unstructured":"Lobner D (2000) Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis. J Neurosci Methods 96:147\u2013152","journal-title":"J Neurosci Methods"},{"key":"133_CR20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.bcp.2005.12.039","volume":"71","author":"RA Alderden","year":"2006","unstructured":"Alderden RA, Mellor HR, Modok S, Hambley TW, Callaghan R (2006) Cytotoxic efficacy of an anthraquinone linked platinum anticancer drug. Biochem Pharmacol 71:1136\u20131145","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"133_CR21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1367-5931(03)00081-4","volume":"7","author":"CX Zhang","year":"2003","unstructured":"Zhang CX, Lippard SJ (2003) New metal complexes as potential therapeutics. Curr Opin Chem Biol 7(4):481\u2013489","journal-title":"Curr Opin Chem Biol"},{"key":"133_CR22","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/ja0432618","volume":"127","author":"WH Ang","year":"2005","unstructured":"Ang WH, Khalaila I, Allardyce CS, Juillerat-Jeanneret L, Dyson PJ (2005) Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance. J Am Chem Soc 127:1382\u20131383","journal-title":"J Am Chem Soc"},{"key":"133_CR23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","volume":"75","author":"C Marzolini","year":"2004","unstructured":"Marzolini C, Paus E, Buclin T, Kim RB (2004) Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 75:13\u201333","journal-title":"Clin Pharmacol Ther"},{"key":"133_CR24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1389557053402756","volume":"5","author":"V Fischer","year":"2005","unstructured":"Fischer V, Einolf HJ, Cohen D (2005) Efflux transporters and their clinical relevance. Min Rev Med Chem 5:183\u2013195","journal-title":"Min Rev Med Chem"},{"key":"133_CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.0306-5251.2001.01499.x","volume":"52","author":"JA Goldstein","year":"2001","unstructured":"Goldstein JA (2001) Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol 52:349\u2013355","journal-title":"Br J Clin Pharmacol"},{"key":"133_CR26","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/sj.onc.1209377","volume":"25","author":"C Rodriguez-Antona","year":"2006","unstructured":"Rodriguez-Antona C, Ingelman-Sundberg M (2006) Cytochrome P450 pharmacogenetics and cancer. Oncogene 25:1679\u20131691","journal-title":"Oncogene"},{"key":"133_CR27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2710.1999.00236.x","volume":"24","author":"E Tanaka","year":"1999","unstructured":"Tanaka E (1999) Update: genetic polymorphism of drug metabolizing enzymes in humans. J Clin Pharm Ther 24:323\u2013329","journal-title":"J Clin Pharm Ther"},{"key":"133_CR28","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0024-3205(96)00507-3","volume":"59","author":"Y Tsuneoka","year":"1996","unstructured":"Tsuneoka Y, Fukushima K, Matsuo Y, Ichikawa Y, Watanabe Y (1996) Genotype analysis of the CYP2C19 gene in the Japanese population. Life Sci 59:1711\u20131715","journal-title":"Life Sci"},{"key":"133_CR29","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3748\/wjg.v10.i13.463","volume":"10","author":"SW Xing","year":"2004","unstructured":"Xing SW, Qing CS (2004) Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population. World J Gastroenterol 10:1961\u20131963","journal-title":"World J Gastroenterol"},{"key":"133_CR30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mrgentox.2004.06.003","volume":"562","author":"Y Yoshiyuki","year":"2004","unstructured":"Yoshiyuki Y, Ken-ichi F, Nakayama K, Suzuki A, Nakamura K, Yamazaki H, Kamataki T (2004) Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase sensitive to various promutagens. Mutat Res 562:151\u2013162","journal-title":"Mutat Res"},{"key":"133_CR31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cbi.2007.02.003","volume":"167","author":"CSR Menezes","year":"2007","unstructured":"Menezes CSR, Gebrim LC, \u00c1vila VMR, Ferreira MJ, Vieira CU, Pavanin LA, Homsi-brandeburgo MI, Hamaguchi A, Silveira-Lacerda EP (2007) Analysis in vivo of antitumor activity, cytotoxicity and interaction between plasmid DNA and the cis-dichlorotetramineruthenium(III) chloride. Chem Biol Interact 167:116\u2013124","journal-title":"Chem Biol Interact"},{"key":"133_CR32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0074-7696(08)62312-8","volume":"68","author":"AH Wyllie","year":"1980","unstructured":"Wyllie AH, Kerr JFR, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68:251\u2013306","journal-title":"Int Rev Cytol"},{"key":"133_CR33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12011-009-8498-3","volume":"135","author":"EP Silveira-Lacerda","year":"2010","unstructured":"Silveira-Lacerda EP, Vilanova-Costa C, Hamaguchi A, Pavanin LA, Goulart LR, Homsi-brandeburgo MI, Santos WB, Soares AM, Nomizo A (2010) The ruthenium complex cis-(dichloro)tetraammineruthenium(III) chloride presents selective cytotoxicity against murine B cell lymphoma (A-20), murine ascitic sarcoma 180 (S-180), human breast adenocarcinoma (SK-BR-3), and human T cell leukemia (Jurkat) tumor cell lines. Biol Trace Elem Res 135:98\u2013111","journal-title":"Biol Trace Elem Res"},{"key":"133_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3260001","volume":"326","author":"GM Cohen","year":"1997","unstructured":"Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326:1\u201316","journal-title":"Biochem J"},{"issue":"1","key":"133_CR35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/excr.2000.4838","volume":"256","author":"SH Kaufmann","year":"2000","unstructured":"Kaufmann SH, Earnshaw WC (2000) Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256(1):42\u201349","journal-title":"Exp Cell Res"},{"issue":"12","key":"133_CR36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0962-8924(01)02173-0","volume":"11","author":"SH Kaufmann","year":"2001","unstructured":"Kaufmann SH, Hengartner MO (2001) Programmed cell death: alive and well in the new millennium. Trends Cell Biol 11(12):526\u2013534","journal-title":"Trends Cell Biol"},{"key":"133_CR37","first-page":"876","volume":"5","author":"SW Fesik","year":"2005","unstructured":"Fesik SW (2005) Promoting apoptosis as a strategy for cancer drug discovery. Nature 5:876\u2013885","journal-title":"Nature"},{"key":"133_CR38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1097-2765(02)00482-3","volume":"9","author":"Y Shi","year":"2002","unstructured":"Shi Y (2002) Mechanisms of caspase activation and inhibition during poptosis. Mol Cell 9:459\u2013470","journal-title":"Mol Cell"},{"key":"133_CR39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2005.01.002","volume":"226","author":"S Kapitza","year":"2005","unstructured":"Kapitza S, Jakupec MA, Uhl M, Keppler BK, Marian B (2005) The heterocyclic ruthenium(III) complex KP1019 (FFC14A) causes DNA damage and oxidative stress in colorectal tumor cells. Cancer Lett 226:115\u2013121","journal-title":"Cancer Lett"},{"key":"133_CR40","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00775-008-0400-9","volume":"13","author":"S Chatterjee","year":"2008","unstructured":"Chatterjee S, Kundu S, Bhattacharya A, Christian G, Hartinger CG, Dyson PJ (2008) The ruthenium(II)\u2013arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53\u2013JNK pathways. JBIC J Biol Inorg Chem 13:1149\u20131155","journal-title":"JBIC J Biol Inorg Chem"},{"key":"133_CR41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10534-014-9715-x","volume":"27","author":"CAST Vilanova-Costa","year":"2014","unstructured":"Vilanova-Costa CAST, Porto HKP, Pereira FC, Lima AP, dos Santos WB, Silveira-Lacerda EP (2014) The ruthenium complexes cis-(dichloro)tetramineruthenium(III) chloride and cis-tetraammine(oxalato)ruthenium(III) dithionate overcome resistance inducing apoptosis on human lung carcinoma cells (A549). Biometals 27:459\u2013469","journal-title":"Biometals"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-014-0133-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12011-014-0133-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-014-0133-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T21:58:29Z","timestamp":1598306309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12011-014-0133-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,25]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["133"],"URL":"https:\/\/doi.org\/10.1007\/s12011-014-0133-2","relation":{},"ISSN":["0163-4984","1559-0720"],"issn-type":[{"value":"0163-4984","type":"print"},{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,25]]}}}